SONIA
TORRES SANCHEZ
Investigadora Doctora Tipo 1
ESTHER MARIA
BERROCOSO DOMINGUEZ
Catedrática de Universidad
Publications by the researcher in collaboration with ESTHER MARIA BERROCOSO DOMINGUEZ (25)
2024
-
N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia
Translational Psychiatry, Vol. 14, Núm. 1
-
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Psychiatry Research, Vol. 331
2023
-
Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis
Journal of Neuroinflammation, Vol. 20, Núm. 1
2022
-
The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia
Frontiers in Pharmacology, Vol. 13
2021
-
A Characterization of the Effects of Minocycline Treatment during Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders
International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 734-748
-
Automated mouse pupil size measurement system to assess locus coeruleus activity with a deep learning-based approach
Sensors, Vol. 21, Núm. 21
-
Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C
European Neuropsychopharmacology, Vol. 46, pp. 14-27
-
P.0150 Therapeutic and preventive efficacy of mangiferin in an experimental model of schizophrenia
34th ECNP Congress – Lisbon 2021 Hybrid
-
P.0252 N-acetylcysteine supplement during pregnancy may prevent some of the behavioral and neuroanatomical deficits in a schizophrenia-like rat model
European Neuropsychopharmacology, Vol. 53, pp. S183-S184
-
P.0886 Cannabinoids in the prevention of behavioral and brain deficits in a schizophrenia-like rat model
European Neuropsychopharmacology, Vol. 53, pp. S649-S650
2019
-
Deep brain stimulation: Mechanisms underpinning antidepressant effects
Neurobiology of Depression: Road to Novel Therapeutics (Elsevier), pp. 375-382
-
Monoaminergic system and depression
Cell and Tissue Research, Vol. 377, Núm. 1, pp. 107-113
-
Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model
European Neuropsychopharmacology, Vol. 29, Núm. 7, pp. 880-896
2018
-
Effect of Deep Brain Stimulation of the ventromedial prefrontal cortex on the noradrenergic system in rats
Brain Stimulation, Vol. 11, Núm. 1, pp. 222-230
-
Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain
Neuropharmacology, Vol. 135, pp. 202-210
2017
-
Cellular and molecular mechanisms triggered by Deep Brain Stimulation in depression: A preclinical and clinical approach
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 73, pp. 1-10
-
Deep brain stimulation: A promising therapeutic approach to the treatment of severe depressed patients - current evidence and intrinsic mechanisms
Psychiatry and Neuroscience Update (Springer International Publishing), pp. 251-264
-
Formación específica para la correcta realización de una comunicaciónoral dirigido a estudiantes de Grado
II Jornadas de Innovación Docente Universitaria UCA
2014
-
Fluoxetine: A case history of its discovery and preclinical development
Expert Opinion on Drug Discovery, Vol. 9, Núm. 5, pp. 567-578
-
Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats
European Neuropsychopharmacology, Vol. 24, Núm. 6, pp. 996-1003